ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,556, issued on Oct. 28.
"Fusion polypeptides for target peptide production" was invented by Christoph Kutzner (Mannheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to fusion polypeptides, nucleic acid molecules encoding such fusion polypeptides and genetically modified cells comprising such nucleic acid molecules. Additionally, the present invention relates to a method for preparing a target peptide and target peptide mixtures."
The patent was filed on April 27, 2021, under Application No. 17/921,508.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...